THE Food and Drug Administration (FDA) has issued a recall of several batches of Triocef oral drops (generic name: Cefixime), an antibiotic used to treat bacterial infections such as pneumonia, bronchitis, and urinary tract infections (UTIs).
The recall, announced in FDA Advisory No. 2025-0093 on February 5, follows a voluntary request from Cathay Drug Company Inc. after inconsistencies were found in the drug’s potency.
According to the FDA, third-party laboratory tests revealed inconsistencies in the assay/potency results of several batches. FDA Director General Dr. Samuel Zacate stated that these inconsistencies raise concerns about the drug’s effectiveness and could lead to either overdosing or underdosing.
Consumers who have purchased the affected batches are urged to return them to the point of purchase for a refund or replacement. The FDA emphasized the importance of using only properly tested and effective medications to ensure patient safety.
